Owner Canag Diagnostics AB

Inventors Rojer, Eva

Agent Shelston IP

Pub. Number AU-B-2002243139

PCT Pub. Number WO2002/074904

Priority 0100938-0 15.03.01 SE

Filing date 15 March 2002

Wipo publication date 3 October 2002

Acceptance publication date 1 February 2007

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

C07K 14/82 (2006.01) Peptides having more than 20 amino acids - Translation products from oncogenes

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/15 (2006.01) Mutation or genetic engineering - Protease inhibitors, e.g. antithrombin, antitrypsin, hirudin

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids